04.01.2015 Views

Clinical study on 5000 patients - F care systems

Clinical study on 5000 patients - F care systems

Clinical study on 5000 patients - F care systems

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

ABSTRACT<br />

Background: Reticular and telengiectasic varicosities are <strong>on</strong>e of the most comm<strong>on</strong> problems<br />

in the general populati<strong>on</strong> effecting predominantly females. They have higher prevalence in<br />

females between 20-70 years with a rate of 55%. Although these varicosities cause pain and<br />

feeling of tiredness, they mostly cause cosmetic problems in <strong>patients</strong>. Schlerotherapy is a gold<br />

standard threapeutical opti<strong>on</strong> for the treatment of reticular and telengiectasies over 0.3 mm.<br />

But for the <strong>on</strong>es smaller than 0.3 mm, there are other opti<strong>on</strong>s such as thermocoagulati<strong>on</strong> with<br />

radiofrequency and laser energy. The aim of this <str<strong>on</strong>g>study</str<strong>on</strong>g> is to evaluate the efficacy of<br />

thermocoagulati<strong>on</strong> method for the treatment of reticular and telengiectasies.<br />

Patients and Methods: Between April 2004 and February 2008 TC 3000 thermocoagulati<strong>on</strong><br />

device had been used in <strong>5000</strong> <strong>patients</strong> for the treatment of reticular and telengiectasic<br />

varicosities. The lesi<strong>on</strong>s were divided into four groups in accordance with the classificati<strong>on</strong> of<br />

telengiectasies as linear, spider, arborized and papillary. Groups c<strong>on</strong>tained 7853, 5123, 4122<br />

and 2757 lesi<strong>on</strong>s respectively. 4753 of the <strong>patients</strong> were female and the mean age was 28.<br />

Mean follow-up time 24.2±11.9 m<strong>on</strong>ths. Improvement findings of the lesi<strong>on</strong>s were evaluated<br />

in five improvement levels.<br />

Results: Improvement levels in lineer telengiectasy group were 100%. But in more<br />

complicated spider, arborized telengiectasies and bluish-purple small reticular varicosities,<br />

this improvement ratio was approximately 75%. 40% of such cases needed sec<strong>on</strong>d and 15%<br />

needed a third applicati<strong>on</strong> of the thermocoagulati<strong>on</strong>. The mean improvement level in all<br />

lesi<strong>on</strong>s was 4.3 after all the treatments. When the lesi<strong>on</strong>s were evaluated according to their<br />

localizati<strong>on</strong>s, efficacy of the treatment was higher at the lesi<strong>on</strong>s that located below the knee,<br />

ankle and feet when compared to the lesi<strong>on</strong>s located over the knee and the external thigh.<br />

C<strong>on</strong>clusi<strong>on</strong>s: Thermocoagulati<strong>on</strong> is an efficient and hope-giving transcutaneous method for<br />

the treatment of small reticular and telengiectasix varicosities that can not be treated<br />

effectively with microsclerosis.<br />

Key words: Reticular veins, telengiectasies, thermocoagulati<strong>on</strong> method.<br />

F <strong>care</strong> <strong>systems</strong> nv www.f<strong>care</strong><strong>systems</strong>.com Tel: +32 3 451 51 45<br />

K<strong>on</strong>tichsesteenweg 54 info@f<strong>care</strong><strong>systems</strong>.com Fax: +32 3 451 51 39<br />

2630 Aartselaar (Belgium

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!